Log in

ASX:RCE - Recce Pharmaceuticals Stock Price, Forecast & News

A$0.32
-0.02 (-5.97 %)
(As of 01/17/2020 04:00 PM ET)
Add
Compare
Today's Range
A$0.31
Now: A$0.32▼
A$0.33
50-Day Range
A$0.25
MA: A$0.32▼
A$0.38
52-Week Range
A$0.13
Now: A$0.32▼
A$0.44
Volume382,361 shs
Average VolumeN/A
Market Capitalization$42.15 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Recce Pharmaceuticals Ltd, a biotechnology company, researches and develops antibiotic drugs in Australia. The company focuses on the development of RECCE 327 that helps to address the problem of antibiotic resistant superbugs. It also develops drugs for the treatment of stomach ulcers and diarrhea. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

Industry, Sector and Symbol

Stock Exchange ASX
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolASX:RCE
Previous Symbol
CUSIPN/A
CIKN/A
Webhttp://www.recce.com.au/
Phone61 2 8075 4585

Debt

Debt-to-Equity Ratio0.41
Current Ratio0.36
Quick Ratio0.35

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$679,624.00
Price / Sales62.02
Cash FlowA$0.00 per share
Price / Cash Flow91.25
Book ValueA$0.00 per share
Price / Book-78.75

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares133,815,000
Market Cap$42.15 million
Next Earnings DateN/A
OptionableNot Optionable

Receive RCE News and Ratings via Email

Sign-up to receive the latest news and ratings for RCE and its competitors with MarketBeat's FREE daily newsletter.


[URGENT] Have you seen this?! (Ad)


I call it my "Dividend Map", and I'll show you exactly where to find the safest companies that pay the highest yields. (HINT: Texas has 6 of these companies sending huge payouts that average 77%!). I'm willing to send you my Map... but only if you

Recce Pharmaceuticals (ASX:RCE) Frequently Asked Questions

What is Recce Pharmaceuticals' stock symbol?

Recce Pharmaceuticals trades on the ASX under the ticker symbol "RCE."

How were Recce Pharmaceuticals' earnings last quarter?

Recce Pharmaceuticals Ltd (ASX:RCE) issued its quarterly earnings data on Wednesday, February, 27th. The company reported ($0.01) earnings per share (EPS) for the quarter. View Recce Pharmaceuticals' Earnings History.

Has Recce Pharmaceuticals been receiving favorable news coverage?

News headlines about RCE stock have trended somewhat positive on Saturday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Recce Pharmaceuticals earned a media sentiment score of 1.5 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Recce Pharmaceuticals.

Who are some of Recce Pharmaceuticals' key competitors?

What other stocks do shareholders of Recce Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Recce Pharmaceuticals investors own include FlexiGroup (FXL), ASE Technology (ASX), IMMUTEP LTD/S (IMMP), Mavenir Systems (MVNR), Organovo (ONVO), Micron Technology (MU), Seres Therapeutics (MCRB), First Graphene (FGR), Turtle Beach (HEAR) and Cree (CREE).

Who are Recce Pharmaceuticals' key executives?

Recce Pharmaceuticals' management team includes the folowing people:
  • Dr. Graham John Hamilton Melrose BSc(Hons), Ph.D., MBA, FRACI, CChem, FAICD, Exec. Chairman & Chief Research Officer (Age 85)
  • Mr. James Hamilton-Bray Graham, Exec. Director and Exec. Director of Marketing & Bus. Devel.
  • Ms. Michele Dilizia, Exec. Director and Exec. Director of Regulatory Affairs & Microbiology
  • Dr. Justin Ward, Principal Quality Chemist
  • Mr. Justin Reynolds, Chief Financial Officer

What is Recce Pharmaceuticals' stock price today?

One share of RCE stock can currently be purchased for approximately A$0.32.

How big of a company is Recce Pharmaceuticals?

Recce Pharmaceuticals has a market capitalization of $42.15 million and generates $679,624.00 in revenue each year. View Additional Information About Recce Pharmaceuticals.

What is Recce Pharmaceuticals' official website?

The official website for Recce Pharmaceuticals is http://www.recce.com.au/.

How can I contact Recce Pharmaceuticals?

The company can be reached via phone at 61 2 8075 4585.


MarketBeat Community Rating for Recce Pharmaceuticals (ASX RCE)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  17 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  33
MarketBeat's community ratings are surveys of what our community members think about Recce Pharmaceuticals and other stocks. Vote "Outperform" if you believe RCE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCE will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2020 by MarketBeat.com Staff

Featured Article: Outstanding Shares, Buying and Selling Stocks
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel